ARGS - Argos Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1111
Avg. Estimate-1.4-1.8-16.2-7
Low Estimate-1.4-1.8-16.2-7
High Estimate-1.4-1.8-16.2-7
Year Ago EPS-7-11.6-32.6-16.2
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1111
Avg. Estimate50k50k280k200k
Low Estimate50k50k280k200k
High Estimate50k50k280k200k
Year Ago Sales164k105k945k280k
Sales Growth (year/est)-69.50%-52.40%-70.40%-28.60%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-6.75-7-5.2-4
EPS Actual-7-11.6-4.2-2
Difference-0.25-4.612
Surprise %-3.70%-65.70%19.20%50.00%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-1.4-1.8-16.2-7
7 Days Ago-1.4-1.8-16.2-7
30 Days Ago-1.4-1.8-16.2-7
60 Days Ago-0.07-0.09-0.81-0.35
90 Days Ago-0.07-0.09-0.81-0.35
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesARGSIndustrySectorS&P 500
Current Qtr.80.00%N/AN/A0.34
Next Qtr.84.50%N/AN/A0.40
Current Year50.30%N/AN/A0.17
Next Year56.80%N/AN/A0.11
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A